双基酶USP9X调节RIT1蛋白的丰富性和瘤性表型
Amanda K Riley1,2, Michael Grant3, Aidan Snell3
1Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
bioRxiv : the preprint server for biology
|December 11, 2023
概括
杜比基因酶USP9X调节肺癌中的RIT1蛋白水平. 由于USP9X的减少,RIT1的丰富性降低,使细胞对EGFR抑制剂重新敏感.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 在肺癌中,RIT1是一种尚未研究的瘤基因.
- RIT1的活动是由蛋白质丰富度调节的,而不是核酸交换.
- 以前USP9X被确定为RIT1突变细胞中的RIT1依赖性.
研究的目的:
- 调查USP9X和RIT1.1之间的监管关系.
- 为了确定USP9X是否影响RIT1蛋白的稳定性和丰度.
- 评估USP9X枯竭对RIT1驱动的瘤原体表型和药物敏感性的影响.
主要方法:
- 使用特定的抑制剂或遗传技术,消耗USP9X.
- 分析RIT1蛋白质的稳定性和丰富性,通过西式涂抹.
- 对EGFR氨酸激酶抑制剂的细胞敏感性的评估.
主要成果:
- 野生类型和突变RIT1都是USP9X的基质.
- USP9X 枯竭显著降低了 RIT1 蛋白质的稳定性和丰度.
- 缺乏USP9X的RIT1突变细胞对EGFR氨酸激酶抑制剂重新敏感.
结论:
- USP9X是RIT1蛋白丰富性和稳定性的关键调节者.
- 在肺癌中,USP9X在RIT1驱动的瘤原体表型中发挥着关键作用.
- 准USP9X可能代表RIT1突变肺癌的治疗策略.
相关概念视频
Regulated Protein Degradation
7.3K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.3K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
The Unfolded Protein Response
4.6K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.6K
The Proteasome
850
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
850


